We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sandoz Files ANDA For Vyvanse, Tries to Crack Shire’s ADHD Hold
Sandoz Files ANDA For Vyvanse, Tries to Crack Shire’s ADHD Hold
May 24, 2011
More generic-drug makers are attacking the exclusivity of Shire’s attention deficit hyperactivity disorder (ADHD) drug franchise as Sandoz has filed an ANDA for Vyvanse.